Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
Compact case
Authors: Srikant M Datar
Published by: Harvard Business Publishing
Originally published in: 2000
Version: 25 May 2000
Revision date: 13-Jan-2020
Length: 5 pages
Data source: Published sources

Abstract

Should Novartis drop 20% of its global pharmaceutical product brands that account for only 3% of its pharmaceutical revenues?
Location:
Industry:
Size:
USD15 billion revenues; 89,000 employees
Other setting(s):
1999

About

Abstract

Should Novartis drop 20% of its global pharmaceutical product brands that account for only 3% of its pharmaceutical revenues?

Settings

Location:
Industry:
Size:
USD15 billion revenues; 89,000 employees
Other setting(s):
1999

Related